Form 4 for CBLL Ceribell, Inc.
Accepted 2026-08-20 20:55:25 ET · period of report 2026-08-18 · accession 0001193125-26-359672 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-20 20:55 | 2026-08-18+ | CBLL | Blumberg Scott | CFO | M - OptEx | $8.47 | +34.5K | 181.6K | +23% | +$292.3K |
| DMT | 2026-08-20 20:55 | 2026-08-18+ | CBLL | Blumberg Scott | CFO | S - Sale+OE | $25.03 | -34.5K | 148.1K | -19% | -$863.6K |
| DMT | 2026-08-20 20:55 | 2026-08-18+ | CBLL | Blumberg Scott | CFO | M - OptEx | $0.00 | -34.5K | 53.3K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-18 | M | A | 690 | $4.70 | 148,811 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. (F2) Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2026. |
| 2 | Common | Common Stock | 2026-08-18 | M | A | 300 | $9.41 | 149,111 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
| 3 | Common | Common Stock | 2026-08-18 | S | D | 990 | $25.00 | 148,121 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
| 4 | Common | Common Stock | 2026-08-19 | M | A | 6,179 | $4.70 | 154,300 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
| 5 | Common | Common Stock | 2026-08-19 | M | A | 27,333 | $9.41 | 181,633 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. |
| 6 | Common | Common Stock | 2026-08-19 | S | D | 33,512 | $25.03 | 148,121 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-08-18 | M | D | 690 | $0.00 | 43,403 | D | $4.70 · — to 2033-02-16 | 690 Common Stock | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. (F4) The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-08-18 | M | D | 300 | $0.00 | 80,633 | D | $9.41 · — to 2034-04-23 | 300 Common Stock | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. (F5) The stock option is fully vested and currently exercisable. |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-08-19 | M | D | 6,179 | $0.00 | 37,224 | D | $4.70 · — to 2033-02-16 | 6,179 Common Stock | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. (F4) The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2026-08-19 | M | D | 27,333 | $0.00 | 53,300 | D | $9.41 · — to 2034-04-23 | 27,333 Common Stock | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. (F5) The stock option is fully vested and currently exercisable. |